Natera, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Natera, Inc. (NTRA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are NTRA insiders buying or selling?
In the last 12 months, Natera, Inc. insiders reported 0 open-market purchases ($0) and 122 sales ($357.8M) — net selling of $357.8M. Since March 2018, Trabud has recorded 729 Form 4 filings for NTRA: 3 buys ($11.6M) and 726 sells ($972.2M).
Source: SEC EDGAR Form 4
What stands out
- No Natera, Inc. insider made an open-market purchase in the last 12 months; the 122 reported open-market sales totaled $357.8M.
Key Statistics (March 2018 – Oct 17, 2026)
Total Form 4 filings
729
SEC EDGAR
Insider filers
17
Insider buys (3)
$11.6M
Insider sells (726)
$972.2M
Insider sentiment
Net sellingNet insider flow of $960.7M in net selling since March 2018, and $357.8M in net selling over the last 12 months.
Recent NTRA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 17, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 50.0K | $402.64 | $20.1M | SEC ↗ |
| Oct 3, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | Sale | 1.3K | $413.31 | $526.1K | SEC ↗ |
| Oct 3, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3.0K | $414.22 | $1.2M | SEC ↗ |
| Sep 26, 2026 | Jonathan Sheena | Director | Sale | 18.1K | $388.01 | $7.0M | SEC ↗ |
| Sep 18, 2026 | Jonathan Sheena | Director | Sale | 9.2K | $351.49 | $3.2M | SEC ↗ |
| Sep 17, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 102.0K | $341.15 | $34.8M | SEC ↗ |
| Sep 12, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 50.0K | $327.97 | $16.4M | SEC ↗ |
| Sep 4, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 18.2K | $325.88 | $5.9M | SEC ↗ |
| Sep 4, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | Sale | 1.7K | $320.99 | $545.0K | SEC ↗ |
| Aug 29, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale | 6.5K | $321.53 | $2.1M | SEC ↗ |
| Aug 15, 2026 | Jonathan Sheena | Director | Sale | 6.0K | $325.32 | $2.0M | SEC ↗ |
| Aug 8, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 2.0K | $320.90 | $641.8K | SEC ↗ |
| Aug 8, 2026 | Jonathan Sheena | Director | Sale | 9.2K | $315.66 | $2.9M | SEC ↗ |
| Aug 6, 2026 | Michael Burkes Brophy | CHIEF FINANCIAL OFFICER | Sale | 795 | $271.74 | $216.0K | SEC ↗ |
| Aug 6, 2026 | Steven Leonard Chapman | CEO AND PRESIDENT | Sale | 3.1K | $266.39 | $819.4K | SEC ↗ |
| Aug 6, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale | 295 | $267.99 | $79.1K | SEC ↗ |
| Aug 6, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 3.4K | $265.58 | $905.6K | SEC ↗ |
| Aug 6, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale | 334 | $267.99 | $89.5K | SEC ↗ |
| Aug 6, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 731 | $267.99 | $195.9K | SEC ↗ |
| Aug 6, 2026 | Jonathan Sheena | Director | Sale | 109 | $267.99 | $29.2K | SEC ↗ |
| Jul 30, 2026 | Jonathan Sheena | Director | Sale | 479 | $257.93 | $123.5K | SEC ↗ |
| Jul 30, 2026 | Matthew Rabinowitz | EXECUTIVE CHAIRMAN | Sale | 1.7K | $260.49 | $447.5K | SEC ↗ |
| Jul 30, 2026 | Daniel Rabinowitz | SEC. AND CHIEF LEGAL OFFICER | Sale | 1.9K | $257.08 | $485.1K | SEC ↗ |
| Jul 30, 2026 | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 2.2K | $257.00 | $569.0K | SEC ↗ |
| Jul 30, 2026 | John Fesko | PRESIDENT, CHIEF BUS. OFFICER | Sale | 1.7K | $257.00 | $440.2K | SEC ↗ |
Showing the 25 most recent of 729 Form 4 filings for Natera, Inc..
Most active NTRA insiders
- Steven Leonard Chapman152 filings
- Jonathan Sheena134 filings
- Michael Burkes Brophy132 filings
- Daniel Rabinowitz70 filings
- Matthew Rabinowitz60 filings
Ask anything about NTRA insider activity
Use Trabud's AI agent to query Natera, Inc.'s Form 4 history in plain English — "Show me NTRA CEO purchases this year" or compare it against any other ticker.
Open the AI agentNTRA insider trading FAQ
Are Natera, Inc. insiders buying or selling?
In the last 12 months, Natera, Inc. insiders reported 0 open-market purchases ($0) and 122 sales ($357.8M) — net selling of $357.8M. Since March 2018, Trabud has recorded 729 Form 4 filings for NTRA: 3 buys ($11.6M) and 726 sells ($972.2M). Over the full record that is net selling of $960.7M.
How many insiders trade NTRA stock?
17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Natera, Inc.. The most recent filing was accepted on Oct 17, 2026.
Where does Trabud get NTRA insider trading data?
All NTRA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.